Tech in the brain: A mission to advance BCIs

Tech in the brain: A mission to advance BCIs

Professor Thomas Oxley (CEO at Synchron) is a vascular and interventional neurologist – and a world-leading expert in brain computer interfaces (BCIs). He has performed more than 1,600 endovascular neurosurgical procedures, giving him a unique perspective into the human brain. 

As founding CEO of Synchron, he’s on a mission to learn more about how our brains work; and create neurotechnology that allows people to control digital devices using their thoughts. With over USD $140 million raised, the company’s first product is in human clinical trials.

We asked Oxley about his fascination with neurology – and he told us one thing he wishes everyone knew about brains. 

How did your work as a neurologist inspire you to found Synchron? 

“When I was in medical school, I often saw patients struggling from neurological disease – with fully functioning minds but unable to move or communicate. I often felt frustrated by the inability to treat or help patients living in these conditions. 

“During that time, I was studying interventional neurology alongside one of my now co-founders, Dr. Rahul Sharma, who was studying interventional cardiology. At the time we were already using catheter-based techniques to treat the likes of heart attacks and now strokes, so I thought – why not use it as a platform to deliver advanced BCI technology? “His love of the heart and my love of the brain was the impetus for starting down the path that led to Synchron.”

People often say that we understand less about the human brain than about the ocean, or space. What's your perspective on this – and are emerging technologies getting us closer to a clear picture of how our brains work? 

“I am endlessly fascinated by all three. One of the reasons we’re approaching BCI in this way, is because it provides access to the brain without disrupting it. 

“Think of the vascular system as the brain's natural highways. If we can reach previously unreachable parts of the brain, we can learn about them. 

“Ultimately, I think the more we learn about how the brain works, the better we’ll understand both others and ourselves. We’re lucky to be living in a time where interventional neurology and tech are rapidly outpacing other advancements in medicine, leading to very powerful advancements in our understanding of and access to the brain.”

You've clearly made huge leaps forwards in terms of what's possible in brain computer interface tech over the last 12 years. Could you tell us the breakthroughs that have been most exciting for you, and most transformative for the patients in your trials? 

“There have been so many moments that have excited our team and patients alike. Over the last 12 years, we’ve seen patients do things like shop, control environmental tech, communicate with loved ones and play Pong. 

“Recently, one of our biggest breakthroughs on the horizon is that we’ve built an automated decoder – the decoder being the piece of tech that interprets brain activity and converts it into a digital motor output, like a ‘click’. We believe we’ve built a decoder that will work out of the box and won’t require individual automation. This is fundamental in making our device easy to use and is an advancement we’re really excited about.”

If there was one thing you wish everyone knew about the human brain, what would it be? 

“I would love for more people to realise that most of our behaviours are driven by unconscious irrational whims. We don’t really know why we do what we do. Actions tend to only be rationalised by the conscious mind after we have already done them. I’m hoping that our work can some day shine a light on how our minds truly work.”

And finally, why are events like LEAP important to you? 

“I’m always eager to attend events like LEAP because it provides an opportunity to drive innovation through exposure to new ideas. It’s a special thing to be in the same room as so many brilliant people, pushing tech forward.” 

Thanks to Thomas Oxley at Synchron, Inc. Did you miss LEAP 2024? Don’t worry – join us in Riyadh for the 2025 edition. 


Precision therapeutics: Informed by genes and enabled by tech

Technological development is driving major leaps forward in human genomics and healthcare. Scaleable sequencing technologies and AI-powered automated data analysis are expediting discoveries in the field of life sciences; and driving a new wave of healthtech companies that have real potential to solve the most serious health challenges faced by

How tech talks to the world

Natalia Brzezinski (Founder and CEO at Absolute Strategies) is the former Global Business Development lead at Klarna, and the former CEO of Brilliant Minds Foundation – bringing together new disruptors and established business groups to explore the relationship between tech and humanity.  She understands that communication is at the heart of

It’s real: A positive relationship between art and tech

LEAP 2024 speaker Otto Plesner (Creative Director at RenaiXance) has a background in theatre and performing arts – and he’s using that creative foundation to imagine new ways for artists to engage with emerging technologies.  In his multi-sensory show The Art of Memory, he blends AI-powered visuals with evocative scents,